Brief: Biomed Lublin Signs Up To 43.2 Mln Zloty Subsidy Deal
Dec 27 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA BML.WA :
* SIGNS SUBSIDY DEAL WITH POLISH AGENCY FOR ENTERPRISE AND
DEVELOPMENT
* SUBSIDY IS FOR DEVELOPMENT OF PRODUCTS RELATED TO BLADDER
CANCER
IMMUNOTHERAPHY
* TOTAL SUBSIDY VALUE UP TO 43.2 MLN ZLOTYS
Source text for Eikon: urn:newsml:reuters.com:*:nEMbstKJHa
Further company coverage: BML.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility